|
||
Original Article |
Bmediated Signals
Correspondence to: James N. Topper, COR Therapeutics, Inc., 256 E. Grand Ave., South San Francisco, CA 94080. Tel:650-244-7333 Fax:650-244-9270 E-mail:jtopper{at}corr.com.
Transforming growth factor (TGF)-ß1 is a pleiotropic cytokine/growth factor that is thought to play a critical role in the modulation of inflammatory events. We demonstrate that exogenous TGF-ß1 can inhibit the expression of the proinflammatory adhesion molecule, E-selectin, in vascular endothelium exposed to inflammatory stimuli both in vitro and in vivo. This inhibitory effect occurs at the level of transcription of the E-selectin gene and is dependent on the action of Smad proteins, a class of intracellular signaling proteins involved in mediating the cellular effects of TGF-ß1. Furthermore, we demonstrate that these Smad-mediated effects in endothelial cells result from a novel competitive interaction between Smad proteins activated by TGF-ß1 and nuclear factor
B (NF
B) proteins activated by inflammatory stimuli (such as cytokines or bacterial lipopolysaccharide) that is mediated by the transcriptional coactivator cyclic AMP response elementbinding protein (CREB)-binding protein (CBP). Augmentation of the limited amount of CBP present in endothelial cells (via overexpression) or selective disruption of SmadCBP interactions (via a dominant negative strategy) effectively antagonizes the ability of TGF-ß1 to block proinflammatory E-selectin expression. These data thus demonstrate a novel mechanism of interaction between TGF-ß1regulated Smad proteins and NF
B proteins regulated by inflammatory stimuli in vascular endothelial cells. This type of signaling mechanism may play an important role in the immunomodulatory actions of this cytokine/growth factor in the cardiovascular system.
Key Words: inflammation, transcription, transforming growth factor, vascular biology, endothelium
This article has been cited by other articles:
| TABLE OF CONTENTS |
|